Guy Lerner - Nextage Therapeutics CEO

MCTC Stock  ILA 37.70  1.30  3.33%   

CEO

Mr. Guy Lerner was appointed Chief Executive Officer at Micromedic Technologies Ltd effective July 17, 2016. His work experience includes the role of Chief Executive Officer at Neetour Medical Ltd for six years. He holds a Bachelors degree in Economics from Tel Aviv University and a MBA degree from Pace University. since 2016.
Age 50
Tenure 8 years
Professional MarksMBA
Phone972 73 2753450
Webhttp://www.m-medic.com

Nextage Therapeutics Management Efficiency

The company has return on total asset (ROA) of (0.3684) % which means that it has lost $0.3684 on every $100 spent on assets. This is way below average. Nextage Therapeutics' management efficiency ratios could be used to measure how well Nextage Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

CEO Age

Ehud ArnonIsrael Discount Bank
65
Lilach ToplinskyIsrael Discount Bank
48
Arnon TorenAzrieli Group
60
Shmuel AntzelDelek Group
57
CecileEsther EldanDelek Group
63
Dina NavotMizrahi Tefahot
Eyal LapidotDelek Group
52
Israel KerenAzrieli Group
76
Nathan HaitchookAlony Hetz Properties
65
Romano VaisenbergerGazit Globe
43
Eitan ZeevBig Shopping Centers
66
Asaf BartfeldDelek Group
66
Eyal ChenkinAzrieli Group
47
Yuval BronsteinAzrieli Group
47
Esther DeutschIsrael Discount Bank
57
Yehuda MilsteinBig Shopping Centers
45
Israel YaaqoviBig Shopping Centers
56
Yosef AbuDelek Group
40
Eyal HankinAzrieli Group
N/A
Rakefet RussakAminoachBank Leumi Le Israel
51
Daniel TsiddonBank Leumi Le Israel
59
Micromedic Technologies Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide. Further, the company provides diagnostic solutions for multiple cancer diagnostic applications. MICROMEDIC TECHNOL operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. Nextage Therapeutics (MCTC) is traded on Tel Aviv Stock Exchange in Israel and employs 6 people.

Management Performance

Nextage Therapeutics Leadership Team

Elected by the shareholders, the Nextage Therapeutics' board of directors comprises two types of representatives: Nextage Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nextage. The board's role is to monitor Nextage Therapeutics' management team and ensure that shareholders' interests are well served. Nextage Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nextage Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Meir Yoeli, Chief Executive Officer
Itai BarNatan, Chief Officer
Guy Lerner, CEO
Yifftach Biel, Deputy Vice President - Finance
Yael Glickman, VP Devel
Doron Debbie, Independent Director

Nextage Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nextage Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nextage Therapeutics. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Nextage Stock analysis

When running Nextage Therapeutics' price analysis, check to measure Nextage Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextage Therapeutics is operating at the current time. Most of Nextage Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nextage Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextage Therapeutics' price. Additionally, you may evaluate how the addition of Nextage Therapeutics to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Please note, there is a significant difference between Nextage Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nextage Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nextage Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.